Steve Melvyn Howdle
Vorsitzender bei The University of Nottingham
Aktive Positionen von Steve Melvyn Howdle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The University of Nottingham | Vorsitzender | - | - |
Karriereverlauf von Steve Melvyn Howdle
Ehemalige bekannte Positionen von Steve Melvyn Howdle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Critical Pharmaceuticals Ltd.
 Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | - |
| Gründer | 01.01.2002 | - |
Statistik
International
| Vereinigtes Königreich | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Chairman | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Steve Melvyn Howdle
- Erfahrung
